Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. - Wikidata - wikimedia - TriplyDB

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

http://www.wikidata.org/entity/Q33996797

about

Asking the right questions: developing evidence-based strategies for treating HIV in women and children Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants Mitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years.Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cords Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.Simultaneous quantification of mitochondrial DNA damage and copy number in circulating blood: a sensitive approach to systemic oxidative stress.Family adversity and autonomic reactivity association with immune changes in HIV-affected school children.Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?Mitochondrial toxicity and caspase activation in HIV pregnant women.Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry.HIV-exposed uninfected children: a growing population with a vulnerable immune system?Complications of Treatment in Youth with HIV.Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.An unusual case of hyperlactataemia in a neonate.Blood Mitochondrial DNA Content in HIV-Exposed Uninfected Children with Autism Spectrum Disorder.

P2860

Q28743488-58E83D25-A1CD-423E-89D8-6FED10BCA7D8 Q33747993-06F19311-D0EA-4581-860A-A1694E6FC1C6 Q34348392-986EA342-48FF-4163-B975-4787581CFDE5 Q34358732-0745ECCC-73DE-4CB0-9704-FEA019A2BA5D Q35074791-87472BD4-6840-4911-920D-280AD89882DB Q35622844-2F40C1DF-07B8-4214-AABD-2CBE600661F8 Q35680819-CB186101-309B-4466-933B-35C2716B3E7A Q35738557-330FD717-6225-4152-ABEC-B1B5489215AD Q35740081-4D58104D-94D6-441A-A45D-72CE085567DE Q36665312-22F958C2-3815-49BE-9386-70DE68EE1763 Q37315334-36134E20-1B08-4874-A440-BE340C3C7F2F Q37342120-8E31FB2E-25F6-4510-9FE1-E10CBE485CBF Q37539856-780DE551-7365-45AC-8709-91E89EC12EB9 Q37552456-CA309CEC-0333-4666-A9D8-899756A973E1 Q37663941-69DA05C2-0008-4CD0-BA04-F36904239CE1 Q38170189-C0915DB2-0993-45FF-98E7-3726BE6840F1 Q38846571-67965B93-4A44-4B04-A08F-BBF21FB3DC9E Q41996509-76E1C031-E9DE-487C-9850-31E6410C30D2 Q42250152-6A362E9F-77D0-418D-B75F-6272F88BB03C Q50034060-42A98AFE-4A7A-4E1D-B362-20C4A3E556D1

P2860

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

http://www.wikidata.org/entity/Q33996797

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@ast

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@en

type

label

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@ast

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@en

prefLabel

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@ast

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@en

P1433

Q33996797-9773E6E7-D3F5-4DDE-A691-5F36A10EEC49

P1476

Q33996797-837052FB-916F-459D-B568-AA97F185F681

P2093

Q33996797-081927A4-0239-498E-918C-7C215789096B

Q33996797-1F344862-6D09-4E9D-863B-52EEFCEF5345

Q33996797-2667B451-7CEA-4618-AEE6-775B21201DA9

Q33996797-31C35EC5-60D1-4BE8-B7F4-8C2E4589F35F

Q33996797-507ED56F-3AB6-43E4-9BBE-E33427C4095A

Q33996797-88A9E80F-4D07-4D6B-AF21-AA93627E7B6B

Q33996797-93CFBDB6-8C46-4EA2-8ED9-D9B4228228BA

Q33996797-AB99700B-0DFD-41E9-A2AF-B4BA196D2078

Q33996797-CFD62A95-DC7B-4D10-9767-37E12712D684

Q33996797-EBDDCCC3-2BD2-4D81-8A55-5AC00F97BA3B

P2860

Q33996797-01A634B5-7515-4F78-AE18-EDA8B80AEAED

Q33996797-0322870B-0D48-4986-92D4-96817E7EE888

Q33996797-09FD36EE-1311-4535-87E9-5DCB9B23824C

Q33996797-1436B027-C13A-48F2-8540-71E2B30C3D08

Q33996797-212EC6B1-4902-4E20-BC9B-1659A65FE9AC

Q33996797-236896DC-34FF-4A1D-997E-539A412BBFFA

Q33996797-2CAC92EC-21C6-4E93-8091-B79D9041D35D

Q33996797-457F71FC-7452-4A9D-9FCA-10BC700D8554

Q33996797-47B9695B-2B35-4D0C-B71A-79C88F4C057F

Q33996797-5FA1C733-92AA-4B39-AF50-FB76630509D6

P304

Q33996797-CC54D38D-0563-46F2-A5A7-1598E2DE7FE8

P31

Q33996797-3A34023B-A4E2-478B-9053-8E399087E79C

P356

Q33996797-F2C966BC-2216-46B9-B804-DC75864E3DE9

P407

Q33996797-7CF255F5-4F48-48DC-B5AF-576028362CDC

P433

Q33996797-BD93CF7E-314C-4218-8EB9-74777849AB55

P478

Q33996797-AC9D6D2D-9743-4784-83C0-86D98F65B128

P50

Q33996797-75101DD8-88BE-4F4A-864F-45FABB3401CA

Q33996797-FB9A24FF-7AEB-48A1-8F32-313F5FB5EB4F

P577

Q33996797-C3955435-FA69-47FD-8B86-44ECFAC1C939

P5875

Q33996797-13AD3A1F-264D-471E-BCA9-53C6C190C1D0

P698

Q33996797-2AE2372B-B0DE-46F1-B9AC-0B3977C95804

P921

Q33996797-39E15B5D-061D-4901-8178-023568E7BBE4

P932

Q33996797-4C63B2DC-B11B-4627-AC30-857325FB5461

P356

P1433

P1476

Antiretroviral exposure and ly ...... fants of HIV-1-infected women.

@en

P2093

Belinda F Ha

http://www.w3.org/2001/XMLSchema#string

Bruce Thompson

http://www.w3.org/2001/XMLSchema#string

Clara Chu

http://www.w3.org/2001/XMLSchema#string

Daner Li

http://www.w3.org/2001/XMLSchema#string

Grace M Aldrovandi

http://www.w3.org/2001/XMLSchema#string

Jan Walter

http://www.w3.org/2001/XMLSchema#string

Kenneth C Rich

http://www.w3.org/2001/XMLSchema#string

Kenneth McIntosh

http://www.w3.org/2001/XMLSchema#string

Marc Foca

http://www.w3.org/2001/XMLSchema#string

William A Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore

Random-effects models for longitudinal data

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine

Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study.

Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance.

Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children < or = 5 years of age, Pediatric Spectrum of HIV Disease project (PSD), USA.

Reactive oxygen and DNA damage in mitochondria.

Developmental programming of health and disease.

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

P304

e1189-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2008-2771

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

William T. Shearer

P577

2009-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40027082

http://www.w3.org/2001/XMLSchema#string

P698

19933732

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2904486

http://www.w3.org/2001/XMLSchema#string